Max Healthcare Institute (543220) Q4 18/19 earnings summary

Executive summary

• FY19 performance reflected lower reported revenue, but service revenue grew and cost controls lifted operating profit; net loss narrowed on a standalone basis.

• Strategic focus shifted toward high-value healthcare services, operational efficiency, clinical quality and broader patient outreach in India and overseas.

Financial highlights

• Standalone FY19 revenue from operations was ₹1,011 crore vs ₹1,059 crore; operating profit before interest and depreciation was ₹78.7 crore, up 44% YoY.

• Standalone cash profit was ₹35 crore, 1.5x prior year; net loss narrowed to ₹23 crore from ₹34.9 crore.

• Consolidated FY19 revenue was ₹1,691 crore vs ₹1,729 crore; operating profit was ₹212 crore vs ₹167 crore.

• Standalone financial statements report total comprehensive loss of ₹23.38 crore and continuing-operations EPS of -₹0.43 for FY19.

Outlook and guidance

• Priorities include sustained revenue growth through new and subdivided clinical programs, accelerated cost optimization and improved productivity of spend, without compromising patient safety or quality.

• Outreach expansion includes 15 patient assistance, OPD and sales centers, plus overseas facilitation centers to support medical value travel.

• Planned performance actions include increasing occupancy, reducing inpatient length of stay, improving ARPOB and lowering dependence on institutional payors due to collection delays and deductions.